Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-18-062810
Filing Date
2018-10-18
Accepted
2018-10-18 17:03:41
Documents
1
Period of Report
2018-10-16

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 5129
  Complete submission text file 0001104659-18-062810.txt   6692
Mailing Address 800 BOYLSTON STREET SUITE 1555 BOSTON MA 02199
Business Address 800 BOYLSTON STREET SUITE 1555 BOSTON MA 02199 617-351-2590
Longwood Fund II, L.P. (Reporting) CIK: 0001543245 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36812 | Film No.: 181128831

Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Issuer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations